by Jessica Casebolt | Sep 11, 2023 | Providers, Tea Leaves
CareFirst BlueCross BlueShield is joining forces with Ryse Health, a company that specializes in providing in-person and virtual care for patients with uncontrolled Type 2 diabetes, hoping to drive better long-term outcomes. Through the partnership, CareFirst’s...
by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
As states and counties spend the first wave of opioid settlement dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used. In some states, law enforcement departments receive opioid settlement money for policing...
by Jessica Casebolt | Sep 11, 2023 | Inequities and SDOH, Tea Leaves
According to a new study, Latino children who live in states with harsher laws that apply to immigrants and systemic prejudice against them are more likely to experience mental health or chronic physical health conditions. The study, published in the journal...
by Jessica Casebolt | Sep 11, 2023 | Life Sciences, Tea Leaves
Amazon is taking aim at easing access to affordable insulin by automatically applying drug-manufacturer-sponsored coupons on more than 15 insulin and diabetes care brands during online checkout. With the coupons, many insulin brands are available to eligible customers...
by Jessica Casebolt | Sep 11, 2023 | Providers, Tea Leaves
A Modern Healthcare article discusses how energy tax incentives and grants from the Inflation Reduction Act of 2022 could save hospitals billions of dollars. The Inflation Reduction Act of 2022 provides direct funding and tax incentive opportunities for health systems...
by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
Researchers say that access to SUD care for Medicaid fee-for-service beneficiaries has improved from 2014 until 2021. Some of the improvements that have occurred are related to offering outpatient treatment and detoxification and a decrease in prior authorizations and...
Recent Comments